NasdaqCM:CORTPharmaceuticals
Is Corcept Therapeutics (CORT) Pricing Make Sense After Recent Volatility In The Share Price
If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move.
The stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years.
Recent coverage has focused on how this price history shapes expectations for Corcept...